Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Gold

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1992
Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. II. Biased T cell receptor V beta expression predominates in spinal cord infiltrating T cellsD P Gold, M Vainiene, B Celnik, et al.
Immunology|October 10, 1998
Rat NKR-P1+ CD3+ T cells: selective proliferation in interleukin-2, diverse T-cell-receptor-Vbeta repertoire and polarized interferon-gamma expressionV Badovinac, C Boggiano, V Trajković, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993
Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitisH Offner, A C Buenafe, M Vainiene, et al.
Autoimmunity|January 1, 1995
T cells from BB-DP rats show a unique cytokine mRNA profile associated with the IDDM1 susceptibility gene, LypD P Gold, S T Shaikewitz, D Mueller, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Gene therapy approaches to enhance antitumor immunityD L Shawler, H Fakhrai, C Van Beveren, et al.
Human Gene Therapy|February 1, 1995
Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I studyR E Sobol, I Royston, H Fakhrai, et al.
Journal of Neuroimmunology|June 1, 1997
Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populationsD B Wilson, A B Golding, R A Smith, et al.
Transplantation Proceedings|December 20, 2000
Cytokine requirement for the development of rat dendritic cells by in vitro culturing of bone marrow cellsY Hua, T Miyagi, H Saito, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1987
The gene encoding the epsilon subunit of the T3/T-cell receptor complex maps to chromosome 11 in humans and to chromosome 9 in miceD P Gold, J J van Dongen, C C Morton, et al.
Transplantation Proceedings|December 20, 2000
GM-CSF-independent development of dendritic cells from bone marrow cells in the GM-CSF-receptor-deficient mouseH Hikino, T Miyagi, Y Hua, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1992
Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. II. Biased T cell receptor V beta expression predominates in spinal cord infiltrating T cellsD P Gold, M Vainiene, B Celnik, et al.
Immunology|October 10, 1998
Rat NKR-P1+ CD3+ T cells: selective proliferation in interleukin-2, diverse T-cell-receptor-Vbeta repertoire and polarized interferon-gamma expressionV Badovinac, C Boggiano, V Trajković, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993
Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitisH Offner, A C Buenafe, M Vainiene, et al.
Autoimmunity|January 1, 1995
T cells from BB-DP rats show a unique cytokine mRNA profile associated with the IDDM1 susceptibility gene, LypD P Gold, S T Shaikewitz, D Mueller, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Gene therapy approaches to enhance antitumor immunityD L Shawler, H Fakhrai, C Van Beveren, et al.
Human Gene Therapy|February 1, 1995
Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I studyR E Sobol, I Royston, H Fakhrai, et al.
Journal of Neuroimmunology|June 1, 1997
Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populationsD B Wilson, A B Golding, R A Smith, et al.
Transplantation Proceedings|December 20, 2000
Cytokine requirement for the development of rat dendritic cells by in vitro culturing of bone marrow cellsY Hua, T Miyagi, H Saito, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1987
The gene encoding the epsilon subunit of the T3/T-cell receptor complex maps to chromosome 11 in humans and to chromosome 9 in miceD P Gold, J J van Dongen, C C Morton, et al.
Transplantation Proceedings|December 20, 2000
GM-CSF-independent development of dendritic cells from bone marrow cells in the GM-CSF-receptor-deficient mouseH Hikino, T Miyagi, Y Hua, et al.
Pageof 8